Advertisement

Search Results for "Cisatracurium Pharmacotherapeutics"

03:42 EDT 24th May 2013 | BioPortfolio

Original Source: Pharmacodynamics

Matching Channels

None

Matching News

Drawbacks in Current Rheumatoid Arthritis Therapies Point to a Large Untapped Market in the U.S., Finds Frost & Sullivan

MOUNTAIN VIEW, Calif., Oct. 18, 2012 /PRNewswire/ -- The availability of tumor necrosis factor (TNF) inhibitors has greatly improved the pharmacological management of rheumatoid arthritis (RA...

Frost & Sullivan: TNF Inhibitors Lay the Groundwork for the Next Generation of Disease-Modifying Anti-Rheumatic Drugs

MOUNTAIN VIEW, Calif., Dec. 5, 2012 /PRNewswire/ -- The challenges inherent in the pharmacological management of rheumatic diseases have stoked huge demand for drug classes with excellent safety...

Lesser Known Ankylosing Spondylitis Pharmacotherapy is an Untapped Market in the United States, Finds Frost & Sullivan

MOUNTAIN VIEW, Calif., Oct. 10, 2012 /PRNewswire/ -- The treatment beyond standard of care for ankylosing spondylitis (AS) pharmacotherapeutics currently consists of a single drug class – tumor...

Absence of Alternative Therapies for Psoriatic Arthritis Signifies a Vast Untouched Market, Finds Frost & Sullivan

MOUNTAIN VIEW, Calif., Oct. 25, 2012 /PRNewswire/ -- Tumor necrosis factor (TNF) inhibitors are currently the only therapeutic class available to psoriatic arthritis (PsA) patients in need of add...

Davis’s Drug Guide for Nurses®, Thirteenth Edition publishes June 2012 in Print, Mobile, and Online

Print, mobile, and online versions of the Thirteenth Edition of Davis’s Drug Guide for Nurses® from F.A. Davis Company publish in June 2012 with up-to-date information on hundreds of generic an...

Long Island Dentist, Dr. Ira D. Koeppel Launches New Website Showcasing Services and Credentials

Long Island Cosmetic Dentist, Dr. Ira D. Koeppel announces the launch of a new website. Long Island, NY (PRWEB) June 16, 2012 When you think of Cosmetic Dentist on Long Island one Dentist stands out,...

Matching PubMed Articles

Cisatracurium pharmacokinetics and pharmacodynamics during hypothermic cardiopulmonary bypass in infants and children.

Background:  Hypothermia potentiates neuromuscular blockade in adults during cardiopulmonary bypass (CPB) but the pediatric literature is sparse. Temperature-dependent Hoffman degradation of cisatra...

Effect of an intravenous infusion of lidocaine on cisatracurium-induced neuromuscular block duration: a randomized-controlled trial.

Background: Intravenous lidocaine can be used intraoperatively for its analgesic and antihyperalgesic properties but local anaesthetics may also prolong the duration of action of neuromuscular blockin...

Perioperative pharmacology: pharmacotherapeutics, pharmacokinetics, and pharmacodynamics.

Results of current research into perioperative medication errors have revealed that more than half of medication errors occur during the administration phase of the medication-use process. The adminis...

Effect of nitrous oxide on cisatracurium infusion demands: a randomized controlled trial.

ABSTRACT: BACKGROUND: Recent studies have questioned our previous understanding on the effect of nitrous oxide on muscle relaxants, since nitrous oxide has been shown to potentiate the action of bolus...

48 hours of cisatracurium reduced 90-day mortality in patients with early, severe ARDS.

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement